Acceleron Pharma Inc
Biotechnology
Healthcare
XLRN
60.72M shares
NASDAQ US
traded
19 Nov 2021
open
179.85
52 week high
182.78
high
179.85
52 week low
110.92
low
177.20
growth
50.4%
previous Close
179.68
P/E ratio
-154
market cap
10.64B
div yield
0
usd
Sep 2021
qoq
revenue
34.20M
22.40 %
net incoming
-70.47M
-10.93 %
eps
-1.16
-10.48 %
eps surprise
-14.48 %
net profit margin
-206.04 %
21.00 %
operating incoming
-70.63M
-10.95 %
net change in cash
-119.26M
0.05 %
cash on hand
336M
0.08 %
cost of revenue
top top